Up-regulation of hnRNP a1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer

World Journal of Gastroenterology

Volumn 16, Issue 37, 2010, Pages 4670-4676

  He, Zhen Yu ^a   Wen, Hao ^a   Shi, Chuan Bing ^b   Wang, Jie ^a,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Micrometastasis; Proteomics; Sentinel lymph node

Indexed keywords

BETA TUBULIN; BETA TUBULIN 2C; EZRIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; LIPOCORTIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECTUM CARCINOMA; SENTINEL LYMPH NODE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 77957729082     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i37.4670     Document Type: Article

References (32)

1. American Cancer Society: Cancer Facts and Figures 2009. Atlanta: American Cancer Society, 2009. Available from: URL: http://www.cancer.org/downloads/STT/500809web.pdf
2. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871-876
3. Rooney PH, Boonsong A, McKay JA, Marsh S, Stevenson DA, Murray GI, Curran S, Haites NE, Cassidy J, McLeod HL. Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer 2001; 85: 1492-1498
4. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998; 83: 666-672
5. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon cancer. Cancer 1991; 67: 1859-1861
6. Medina-Franco H, Takahashi T, González-Ruiz GF, De-Anda J, Velazco L. Sentinel lymph node biopsy in colorectal cancer: a pilot study. Rev Invest Clin 2005; 57: 49-54
7. Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Si-phos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horst-mann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007; 245: 858-863
8. Bembenek A, String A, Gretschel S, Schlag PM. Technique and clinical consequences of sentinel lymph node biopsy in colorectal cancer. Surg Oncol 2008; 17: 183-193
9. Dionigi G, Castano P, Rovera F, Boni L, Annoni M, Villa F, Bianchi V, Carrafello G, Bacuzzi A, Dionigi R. The application of sentinel lymph node mapping in colon cancer. Surg Oncol 2007; 16 Suppl 1: S129-S132
10. Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer. ANZ J Surg 2008; 78: 775-779
11. Ivanov K, Kolev N, Ignatov V, Madjov R. Intraoperative sentinel lymph node mapping in patients with colorectal cancer. Hepatogastroenterology 2009; 56: 99-105
12. Roblick UJ, Auer G. Proteomics and clinical surgery. Br J Surg 2005; 92: 1464-1465
13. Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H. Proteome analysis and tissue micro array for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 2007; 6: 2495-2501
14. Xing X, Lai M, Gartner W, Xu E, Huang Q, Li H, Chen G. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Pro-teomics 2006; 6: 2916-2923
15. Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim H, Lee C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 2009; 8: 1368-1379
16. Yu B, Li SY, An P, Zhang YN, Liang ZJ, Yuan SJ, Cai HY. Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer. World J Gastro-enterol 2004; 10: 2652-2656
17. Saint-Guirons J, Zeqiraj E, Schumacher U, Greenwell P, Dwek M. Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA). Proteomics 2007; 7: 4082-4089
18. Fung KY, Lewanowitsch T, Henderson ST, Priebe I, Hoffmann P, McColl SR, Lockett T, Head R, Cosgrove LJ. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells. J Proteome Res 2009; 8: 1220-1227
19. Braat AE, Oosterhuis JW, Moll FC, de Vries JE. Successful sentinel node identifcation in colon carcinoma using Patent Blue V. Eur J Surg Oncol 2004; 30: 633-637
20. Kaneko I, Tanaka S, Oka S, Kawamura T, Hiyama T, Ito M, Yoshihara M, Shimamoto F, Chayama K. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis Colon Rectum 2007; 50: 13-21
21. John CD, Gavins FN, Buss NA, Cover PO, Buckingham JC. Annexin A1 and the formyl peptide receptor family: neuro-endocrine and metabolic aspects. Curr Opin Pharmacol 2008; 8: 765-776
22. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008; 98: 426-433
23. Kim DM, Noh HB, Park DS, Ryu SH, Koo JS, Shim YB. Im-munosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer. Biosens Bioelectron 2009; 25: 456-462
24. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61: 889-895
25. Wang HJ, Zhu JS, Zhang Q, Sun Q, Guo H. High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol 2009; 15: 2016-2019
26. Elzagheid A, Korkeila E, Bendardaf R, Buhmeida A, Heik-kilä S, Vaheri A, Syrjänen K, Pyrhönen S, Carpén O. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol 2008; 39: 1737-1743
27. Yeh TS, Tseng JH, Liu NJ, Chen TC, Jan YY, Chen MF. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg 2005; 140: 1184-1190
28. Portyanko A, Kovalev P, Gorgun J, Cherstvoy E. beta(III)-tubulin at the invasive margin of colorectal cancer: possible link to invasion. Virchows Arch 2009; 454: 541-548
29. Buxadé M, Parra JL, Rousseau S, Shpiro N, Marquez R, Mor-rice N, Bain J, Espel E, Proud CG. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphory-late and regulate hnRNP A1. Immunity 2005; 23: 177-189
30. Zech VF, Dlaska M, Tzankov A, Hilbe W. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 2006; 30: 395-402
31. Ushigome M, Ubagai T, Fukuda H, Tsuchiya N, Sugimura T, Takatsuka J, Nakagama H. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int J Oncol 2005; 26: 635-640
32. Melle C, Osterloh D, Ernst G, Schimmel B, Bleul A, von Eg-geling F. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry. Int J Mol Med 2005; 16: 11-17